Matches in Wikidata for { <http://www.wikidata.org/entity/Q64047800> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q64047800 description "clinical trial" @default.
- Q64047800 description "ensayu clínicu" @default.
- Q64047800 description "klinisch onderzoek" @default.
- Q64047800 description "клінічне випробування" @default.
- Q64047800 name "Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies" @default.
- Q64047800 type Item @default.
- Q64047800 label "Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies" @default.
- Q64047800 prefLabel "Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies" @default.
- Q64047800 P1050 Q64047800-015BEC6D-FD21-459A-B4AB-DB9F85FE5E5D @default.
- Q64047800 P1132 Q64047800-16DEBC83-C945-44A3-BC18-01811260866D @default.
- Q64047800 P131 Q64047800-B668C1D7-530B-4290-9FFB-0DDB0FB11159 @default.
- Q64047800 P1476 Q64047800-27080055-2BC8-4216-9116-96DD0B4F5630 @default.
- Q64047800 P17 Q64047800-089F1D8E-E90D-4ADF-B93E-9DA76FCD77BA @default.
- Q64047800 P17 Q64047800-0B6DD416-7BE6-4DB4-A959-865D8BD6F106 @default.
- Q64047800 P17 Q64047800-1AF53937-F7BD-4F3B-824C-1D9978B2A663 @default.
- Q64047800 P17 Q64047800-4A00532D-3041-4F5F-9BB8-F704FBECD1A2 @default.
- Q64047800 P17 Q64047800-7EDDE749-F159-4026-A30A-EC5F04DF7755 @default.
- Q64047800 P17 Q64047800-B063649F-5FF0-41A4-A1FF-80352CACFB3F @default.
- Q64047800 P17 Q64047800-B834103F-5906-49F4-B31A-7947BD03B5C3 @default.
- Q64047800 P17 Q64047800-D04D2A92-A28F-4546-B3A1-F68C0E60BD72 @default.
- Q64047800 P17 Q64047800-F65C1FD5-0608-4542-9D12-C10215A52594 @default.
- Q64047800 P2899 Q64047800-55133AC3-B462-4A78-A5C1-8DD1B24F0E7F @default.
- Q64047800 P3098 Q64047800-3DE87229-2A0E-4232-A542-DEE6B291944C @default.
- Q64047800 P31 Q64047800-8120BE54-215D-4DC0-B67D-FE4E0E17C7B9 @default.
- Q64047800 P580 Q64047800-7D2A9EBC-6B63-4139-9A3D-6F94546CBC64 @default.
- Q64047800 P582 Q64047800-1ED1AFBD-BE38-4D2F-85E3-FE538C3185A5 @default.
- Q64047800 P6099 Q64047800-9A87657A-1A1B-4ADF-9DE5-F26160A9CFF8 @default.
- Q64047800 P6099 Q64047800-A384A6D1-B57B-4109-A645-E0B12C32EA3B @default.
- Q64047800 P6153 Q64047800-4331D8AF-9372-4771-A8D5-5551C24BA980 @default.
- Q64047800 P6153 Q64047800-FC5415DC-AED4-43BF-9985-3F86E3DCA140 @default.
- Q64047800 P8363 Q64047800-8941515D-6F11-4EED-AE75-B8FECE42B504 @default.
- Q64047800 P859 Q64047800-DDDE7CDB-5093-42F5-8E08-D95C4401CE53 @default.
- Q64047800 P1050 Q208414 @default.
- Q64047800 P1132 "+111" @default.
- Q64047800 P131 Q8646 @default.
- Q64047800 P1476 "A Phase IA/II, Multi-center, Open-label Study of HCD122 Administered Intravenously Once Weekly for Four Weeks in Adult Patients With Advanced Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies (CHIR-12.12-LYM-01)" @default.
- Q64047800 P17 Q142 @default.
- Q64047800 P17 Q145 @default.
- Q64047800 P17 Q16 @default.
- Q64047800 P17 Q183 @default.
- Q64047800 P17 Q30 @default.
- Q64047800 P17 Q31 @default.
- Q64047800 P17 Q334 @default.
- Q64047800 P17 Q38 @default.
- Q64047800 P17 Q408 @default.
- Q64047800 P2899 "+18" @default.
- Q64047800 P3098 "NCT00670592" @default.
- Q64047800 P31 Q30612 @default.
- Q64047800 P580 "2008-03-01T00:00:00Z" @default.
- Q64047800 P582 "2013-02-01T00:00:00Z" @default.
- Q64047800 P6099 Q42824440 @default.
- Q64047800 P6099 Q5452194 @default.
- Q64047800 P6153 Q309350 @default.
- Q64047800 P6153 Q507154 @default.
- Q64047800 P8363 Q78089383 @default.
- Q64047800 P859 Q507154 @default.